Related Experiment Video

Updated: Feb 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.3K

Mitochondrial C4375T mutation might be a molecular risk factor in a maternal Chinese hypertensive family under

Hong Chen1,2, Min Sun1,2, Zhen Fan1,2

  • 1a Intensive Care Unit , Ningbo First Hospital, Ningbo, China.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|December 5, 2017
PubMed

Insights

Researchers identified a mitochondrial DNA mutation (C4375T) in a Han Chinese family with essential hypertension. This mutation, along with Eastern Asian haplogroup C, may contribute to hypertension development and modify its severity.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Essential hypertension is a complex cardiovascular disease with a significant genetic component.
  • Mitochondrial DNA (mtDNA) mutations have been implicated in various human diseases, including cardiovascular conditions.
  • Understanding the genetic basis of hypertension in diverse populations is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the molecular basis of essential hypertension in a Han Chinese family.
  • To identify potential genetic factors, including mitochondrial DNA mutations, contributing to hypertension in this pedigree.
  • To explore the role of haplogroup C in modulating hypertension phenotype.

Main Methods:

  • Clinical data collection and pedigree analysis of an essential hypertensive Han Chinese family.
  • Whole mitochondrial genome sequencing of a proband to identify genetic variations.
  • Phylogenetic analysis to assess the conservation of identified mutations across species.
  • Haplogroup analysis to determine matrilineal lineage.

Main Results:

  • A novel C4375T mutation in the mitochondrial genome was identified in matrilineal members of the hypertensive family.
  • The mutation segregated with affected individuals across generations, showing variable age of onset and disease severity.
  • Phylogenetic analysis revealed that the C4375 nucleotide is highly conserved across 17 species.
  • Affected individuals belonged to Eastern Asian haplogroup C, suggesting its potential involvement.

Conclusions:

  • The identified C4375T mitochondrial DNA mutation is a potential contributor to the development of essential hypertension in this Han Chinese family.
  • Eastern Asian haplogroup C may play a modifying role in the phenotype of hypertension within this specific Chinese hypertensive family.
  • Further research is warranted to elucidate the precise mechanism by which this mtDNA mutation and haplogroup influence hypertension.

Keywords:
Hypertensiongene mutationhalopgroupmatrilinealmitochondrial DNA

More Related Videos

Author Spotlight: Unveiling Mitochondrial Contact Sites and Architectural Insights07:55

Author Spotlight: Unveiling Mitochondrial Contact Sites and Architectural Insights

Published on: June 16, 2023

2.0K
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.2K

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
10
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
10
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.5K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
18.2K